Form EFFECT Sunshine Biopharma Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 7, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qosina Sponsors BayCath Medical’s Innovation Week 2026
- Japan Gold Corp. to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14, 2026
- CureMD Earns ISO/IEC 42001 Certification for Responsible AI as It Advances Agentic Care
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share